Related Experiment Video
Updated: Sep 29, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
[Onset of Testicular Plasmacytoma in a Patient with Refractory Multiple Myeloma]
Akiko Kin1, Masahiro Manabe, Nobuhiro Sogabe
1Dept. of Hematology, Osaka General Hospital of West Japan Railway Company.
Abstract:
A 72-year-old male patient, who had been on chemotherapy for the treatment of IgG-λ multiple myeloma, presented an enlargement of the testis 3 years and 5 months after the diagnosis. High orchiectomy was then performed, leading to the diagnosis of plasmacytoma. Due to residual disease, treatment with a combination of isatuximab and dexamethasone was initiated. The patient is currently under follow-up without recurrence. While testicular tumors are difficult to diagnose by imaging studies alone and extramedullary plasmacytomas rarely occur in the testis, pathological assessment is critical for treatment planning.

